Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yamato Keidai"'
Autor:
Ryo Ito, Azuma Kimura, Yurie Hirose, Yu Hatano, Atsushi Mima, Shin-Ichi Mae, Yamato Keidai, Toshihiro Nakamura, Junji Fujikura, Yohei Nishi, Akira Ohta, Taro Toyoda, Nobuya Inagaki, Kenji Osafune
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract For pluripotent stem cell (PSC)-based regenerative therapy against diabetes, the differentiation efficiency to pancreatic lineage cells needs to be improved based on the mechanistic understanding of pancreatic differentiation. Here, we aimed
Externí odkaz:
https://doaj.org/article/df2cb19d80214e9ca8bdf82af4846cfd
Autor:
Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki, Nobuya Inagaki
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF) risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying factors remain incompletely understood. We aimed to determine th
Externí odkaz:
https://doaj.org/article/7c66de8a2c394852a861e33ded66de9e
Autor:
Yamato Keidai, Junji Fujikura, Toshihiro Nakamura, Takayuki Anazawa, Ryo Ito, Masahito Ogura, Etsuro Hatano, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 11, Pp 1939-1942 (2022)
ABSTRACT Insulin antibodies (IAs) can cause glycemic variability. Islet transplantation (ITx) is a treatment for insulin‐deficient diabetes that aims to establish on‐target glycemic control in the absence of hypoglycemia. To date, there has not b
Externí odkaz:
https://doaj.org/article/f058a7404cf84531910e6036946f557c
Autor:
Masashi Hasebe, Yorihiro Iwasaki, Yamato Keidai, Kanako Iwasaki, Sachiko Honjo, Akihiro Hamasaki
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 11, Pp 1934-1938 (2022)
ABSTRACT Plant sterol intake is widely recommended for patients with cardiovascular risk factors based on the inhibitory effect on intestinal cholesterol absorption. Although plant sterols, once absorbed, can promote atherosclerosis, their intake is
Externí odkaz:
https://doaj.org/article/d0021a1e02df40849cd3d9fcab3514c8
Autor:
Yamato Keidai, Takaaki Murakami, Nana Yamamura, Shigeru Tsunoda, Atsushi Ikeda, Koya Hida, Mototsugu Nagao, Yosuke Yamada, Ayaka Fukui, Masahito Ogura, Izumi Fukuda, Yuji Nakamoto, Kazutaka Obama, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundNon-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome caused by a tumor-producing high molecular weight form of insulin-like growth factor 2 (IGF2) known as big IGF2. The only curative treatment for this condition is s
Externí odkaz:
https://doaj.org/article/1a8f6d28b75f4114a9208798072f6ab4
Autor:
Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki, Nobuya Inagaki
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/834466c6520d421dab6555f46748ceac
Autor:
Yamato Keidai, Yorihiro Iwasaki, Sachiko Honjo, Megumi Aizawa‐Abe, Kanako Iwasaki, Akihiro Hamasaki
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 1116-1117 (2019)
Externí odkaz:
https://doaj.org/article/0e89d92d91fe4e8ba73a3588841bd974
Autor:
Yamato Keidai, Satoshi Yoshiji, Masashi Hasebe, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Nobuya Inagaki
Publikováno v:
Diabetes, Obesity and Metabolism.
Autor:
Masashi Hasebe, Yorihiro Iwasaki, Yamato Keidai, Kanako Iwasaki, Sachiko Honjo, Akihiro Hamasaki
Publikováno v:
Journal of Diabetes Investigation. 13:1934-1938
Autor:
Satoshi Yoshiji, Masashi Hasebe, Yorihiro Iwasaki, Kimitaka Shibue, Yamato Keidai, Yohei Seno, Kanako Iwasaki, Sachiko Honjo, Jun Fujikawa, Akihiro Hamasaki
Publikováno v:
Diabetes Therapy. 13:733-746
Previous studies suggested that β-cell function markers such as fasting and postprandial serum C-peptide and C-peptide increment (FCPR, PCPR, and ΔCPR, respectively) may be useful in estimating glycemic response to glucagon-like peptide-1 receptor